Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...

Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...

Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...

Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor ...

CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it ...

Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...

Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral ...

InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...